| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-22 19:49:56 UTC |
|---|
| Update Date | 2021-09-14 15:43:11 UTC |
|---|
| HMDB ID | HMDB0061132 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Celecoxib glucuronide |
|---|
| Description | Celecoxib glucuronide is a metabolite of celecoxib and is only found in individuals that have used or taken this drug (PMID: 10681375 ). Celecoxib (trade name: Celebrex) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation, and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. Celecoxib is available by prescription in capsule form (Wikipedia). |
|---|
| Structure | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(C=C1)C(=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C(F)(F)F InChI=1S/C23H20F3N3O10S/c24-23(25,26)15-9-14(29(28-15)12-5-7-13(8-6-12)40(27,36)37)10-1-3-11(4-2-10)21(35)39-22-18(32)16(30)17(31)19(38-22)20(33)34/h1-9,16-19,22,30-32H,(H,33,34)(H2,27,36,37)/t16-,17-,18+,19-,22-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Celecoxib beta-D-glucopyranuronide | HMDB | | Celecoxib β-D-glucopyranuronide | HMDB | | Celecoxib glucuronide | HMDB |
|
|---|
| Chemical Formula | C23H20F3N3O10S |
|---|
| Average Molecular Weight | 587.48 |
|---|
| Monoisotopic Molecular Weight | 587.082149519 |
|---|
| IUPAC Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{4-[1-(4-sulfamoylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoyloxy}oxane-2-carboxylic acid |
|---|
| Traditional Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{4-[2-(4-sulfamoylphenyl)-5-(trifluoromethyl)pyrazol-3-yl]benzoyloxy}oxane-2-carboxylic acid |
|---|
| CAS Registry Number | 264236-79-5 |
|---|
| SMILES | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(C=C1)C(=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C(F)(F)F |
|---|
| InChI Identifier | InChI=1S/C23H20F3N3O10S/c24-23(25,26)15-9-14(29(28-15)12-5-7-13(8-6-12)40(27,36)37)10-1-3-11(4-2-10)21(35)39-22-18(32)16(30)17(31)19(38-22)20(33)34/h1-9,16-19,22,30-32H,(H,33,34)(H2,27,36,37)/t16-,17-,18+,19-,22-/m0/s1 |
|---|
| InChI Key | ZSTBSABHKHAHNU-QUXXCFOZSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as o-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | O-glucuronides |
|---|
| Alternative Parents | |
|---|
| Substituents | - O-glucuronide
- 1-o-glucuronide
- Phenylpyrazole
- Benzenesulfonamide
- Benzoate ester
- Benzoic acid or derivatives
- Benzenesulfonyl group
- Benzoyl
- Beta-hydroxy acid
- Benzenoid
- Monosaccharide
- Hydroxy acid
- Organosulfonic acid amide
- Dicarboxylic acid or derivatives
- Oxane
- Monocyclic benzene moiety
- Pyran
- Azole
- Heteroaromatic compound
- Aminosulfonyl compound
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Pyrazole
- Secondary alcohol
- Carboxylic acid ester
- Polyol
- Acetal
- Oxacycle
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organoheterocyclic compound
- Carbonyl group
- Organohalogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Organosulfur compound
- Organonitrogen compound
- Organofluoride
- Alkyl fluoride
- Alkyl halide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 208.103 | 30932474 | | DeepCCS | [M-H]- | 206.278 | 30932474 | | DeepCCS | [M-2H]- | 239.844 | 30932474 | | DeepCCS | [M+Na]+ | 213.709 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.41 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.5224 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.7 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1761.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 213.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 129.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 180.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 111.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 416.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 483.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 492.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 808.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 418.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1330.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 379.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 325.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 249.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 223.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Celecoxib glucuronide,1TMS,isomer #1 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@H]1O | 4412.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TMS,isomer #2 | C[Si](C)(C)O[C@@H]1[C@@H](O)[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)O[C@H](C(=O)O)[C@H]1O | 4406.2 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TMS,isomer #3 | C[Si](C)(C)O[C@H]1[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O | 4415.8 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TMS,isomer #4 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O | 4374.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TMS,isomer #5 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4449.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O[Si](C)(C)C | 4364.0 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #10 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4375.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #11 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4412.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #2 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@H]1O | 4398.8 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #3 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@H]1O[Si](C)(C)C | 4387.6 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #4 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)C=C1 | 4391.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #5 | C[Si](C)(C)O[C@H]1[C@H](O)[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@@H]1O[Si](C)(C)C | 4390.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #6 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]1O | 4345.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #7 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)C=C1 | 4387.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #8 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]1O | 4358.7 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TMS,isomer #9 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4392.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]1O[Si](C)(C)C | 4376.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #10 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)C=C1 | 4352.8 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #11 | C[Si](C)(C)O[C@@H]1[C@@H](O)[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)O[C@H](C(=O)O)[C@H]1O | 4387.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #12 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4356.6 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #13 | C[Si](C)(C)O[C@H]1[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O | 4392.7 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #14 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O | 4373.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 4370.7 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)C=C1 | 4372.0 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](O[Si](C)(C)C)[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)O[C@H](C(=O)O)[C@H]1O[Si](C)(C)C | 4407.6 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #5 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4380.3 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #6 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)C=C1 | 4374.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #7 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O)[C@H]1O | 4399.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #8 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]1O | 4369.2 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,3TMS,isomer #9 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4368.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 4402.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #10 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]1O | 4379.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #11 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]1O | 4380.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #2 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4377.3 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)C=C1 | 4374.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #4 | C[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O[Si](C)(C)C | 4396.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #5 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4403.2 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #6 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O[Si](C)(C)C)[C@H]1O | 4399.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #7 | C[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@H](O)[C@H]1O[Si](C)(C)C | 4407.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #8 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)C=C1 | 4371.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,4TMS,isomer #9 | C[Si](C)(C)O[C@H]1[C@H](O)[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C3)C=C2)[C@@H]1O[Si](C)(C)C | 4393.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@H]1O | 4621.7 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](O)[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)O[C@H](C(=O)O)[C@H]1O | 4623.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@H]1[C@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)O[C@H](C(=O)O)[C@@H](O)[C@@H]1O | 4624.6 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O | 4614.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,1TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4672.7 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 4776.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #10 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4788.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #11 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1 | 4867.2 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O | 4793.9 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C | 4782.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)C=C2)C=C1 | 4790.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)O[C@H]1[C@H](O)[C@@H](C(=O)O)O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@@H]1O[Si](C)(C)C(C)(C)C | 4773.5 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 4764.3 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)C=C2)C=C1 | 4796.1 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #8 | CC(C)(C)[Si](C)(C)OC(=O)[C@H]1O[C@@H](OC(=O)C2=CC=C(C3=CC(C(F)(F)F)=NN3C3=CC=C(S(N)(=O)=O)C=C3)C=C2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]1O | 4772.4 | Semi standard non polar | 33892256 | | Celecoxib glucuronide,2TBDMS,isomer #9 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)C=C1 | 4787.2 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS ("Celecoxib glucuronide,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_2_11) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Celecoxib glucuronide GC-MS (TMS_3_8) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 10V, Negative-QTOF | splash10-000i-2400390000-47bb7e48ac2fdcf2f248 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 20V, Negative-QTOF | splash10-03xr-9201740000-26873834942f6c631d21 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 40V, Negative-QTOF | splash10-07yi-9000230000-e303c394800479e94333 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 10V, Positive-QTOF | splash10-0006-0309030000-7533ac10582ef03d2b93 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 20V, Positive-QTOF | splash10-0006-0209110000-43d14aa119944594bf23 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Celecoxib glucuronide 40V, Positive-QTOF | splash10-014l-1329200000-e9bd4849fc82c9d950b2 | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|